Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 06, 2023

First-Line Systemic Treatment Strategies in Patients With Initially Unresectable Colorectal Cancer Liver Metastases

The Lancet Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Oncology
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
Lancet Oncol 2023 Jun 14;[EPub Ahead of Print], MJG Bond, K Bolhuis, OJL Loosveld, JWB de Groot, H Droogendijk, HH Helgason, MP Hendriks, JM Klaase, G Kazemier, MSL Liem, AM Rijken, C Verhoef, JHW de Wilt, KP de Jong, MF Gerhards, MJ van Amerongen, MRW Engelbrecht, KP van Lienden, IQ Molenaar, B de Valk, BCM Haberkorn, ED Kerver, F Erdkamp, RJ van Alphen, D Mathijssen-van Stein, A Komurcu, M Lopez-Yurda, RJ Swijnenburg, CJA Punt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading